|
(MoneyNewsWire.Net, February 01, 2018 ) The North America Ophthalmic Drugs market size was around USD 10.5 billion in 2017. It is expected to grow at a CAGR of 4.7% to reach USD 13.21 billion by 2022. It captures 35% of the global market.
Ophthalmic drugs are used for the treatment of various eye disorders like cataract, glaucoma etc.
Increasing number of people suffering from glaucoma all over the world, high innovation in and heavy funding in the development of combination therapies are the major factors driving the growth of this market.
Browse Market data tables and in-depth TOC of the North America Ophthalmic Drugs Market to 2022 @ https://www.marketdataforecast.com/market-reports/borth-america-ophthalmic-drugs-market-5488/
Adverse side-effects and long gestation periods in the development of new drugs are the factors hampering market growth.
The market is segmented by therapeutic class, product type, disease indication, distribution channel, dosage form and technology. Classification by disease indication entails Allergy, Dry Eye, Retinal Disorders, Glaucoma, Infection/Inflammation, Uveitis, and others. Retinal disorders captured largest market share however glaucoma is anticipated to grow with the highest CAGR in the forecast period. Classification by therapeutic class entails Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, and others. Classification by product type entails Over-the-Counter Drugs and Prescription Drugs. Classification by distribution channel entails Hospital Pharmacies, Independent Pharmacies & Drug Stores and Online Pharmacies. Classification by dosage form entails Solid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Semisolid Ophthalmic Drug Forms, Liquid Ophthalmic Drug Forms, and Other Ophthalmic Drug Forms. Liquid Ophthalmic drug market sub-category is expected to retain its lead in the market in the forecast period as it is predicted to grow with the highest CAGR in the forecast period. Classification by technology entails Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small molecule, and others.
Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/borth-america-ophthalmic-drugs-market-5488/request-sample
Classification by geography entails US and Canada. North America captures the largest market share due to higher market penetration by the US.
Key players in the market are Carl-Zeiss AG, Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A, Abbott Medical Optics, Inc., Essilor International S.A. Other players in the market include Insight Vision Inc., Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/borth-america-ophthalmic-drugs-market-5488/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
